Results 111 to 120 of about 1,660 (188)

Fosmidomycin antibacterial activity in GlpT deficient E. coli.

, 2018
GlpT transporter-containing (■ BW25113) and deficient ( ΔglpT BW25113) E. coli strains treated with 2800 μM (512 μg/mL) fosmidomycin in CAMHB (a), M9-glucose (b), and M9-glycerol (c) growth medium.
Sara Sanders (4163479), Caren L. Freel Meyers (2026792), Paul D. Phillips (584411), Andrew T. Koppisch (584413), David Bartee (1322541), Mackenzie J. Harrison (4163482)   +5 more
core   +1 more source

Inhibition of the Non-Mevalonate Isoprenoid Pathway by Reverse Hydroxamate Analogues of Fosmidomycin

, 2015
The non-mevalonate (methylerythritol phosphate, MEP) pathway for isoprenoid biosynthesis is essential in Plasmodium spp.., but is absent in the human host.
Gräwert, Tobias, Tanaka, Nobutada, Konzuch, Sarah, Kurz, Thomas, Illarionov, Boris, Bacher, Adelbert, Lienau, Claudia, Fischer, Markus   +7 more
core   +1 more source

Fosmidomycin for the Treatment of Canine Otitis Externa: A Randomised, Double-Blinded, Controlled 'Split Body' Clinical Trial. [PDF]

Vet Dermatol
Citron LE, Stefanovski D, You Y, Proctor R, Watson D, Randall J, Cain CL.   +6 more
europepmc   +1 more source

Sensitivity to fosmidomycin using human plasma.

(A) The images display mass spectrometry obtained using GC-MS triple quadrupole MRM analysis of the standard of GGOH, as well as GGOH detected in human plasma and AlbuMax I. GGOH is highlighted with arrows.
Agustín Hernández (4752078), Miriam Ramirez (17854743), Marcell Crispim (4752069), Thales Kronenberger (4751028), Àngel Fenollar (17854737), María Pía Alberione (17854740), Sandra Souza de Oliveira (17854746), Alejandro Miguel Katzin (13117448), Ignasi Bofill Verdaguer (12440769), Lydia Fumiko Yamaguchi (14200421), Luis Izquierdo (825429)   +10 more
core   +1 more source

The <i>Pseudomonas aeruginosa</i> DedA protein PA4029 is an undecaprenyl phosphate flippase important for polymyxin resistance. [PDF]

mBio
Sposato D, Wang Y, Zhang X, Rossi L, De Chiara S, Di Lorenzo F, Leoni L, Rampioni G, Visca P, Bolla JR, Imperi F.   +10 more
europepmc   +1 more source

Recent advances in natural and synthetic phosphonate therapeutics. [PDF]

Curr Opin Microbiol
Cui J, Ju KS.
europepmc   +1 more source

The early human interferon gamma response to Toxoplasma gondii is driven by Vγ9Vδ2 T-cell sensing of host phosphoantigens and subsequent NK-cell activation. [PDF]

PLoS Pathog
Rodriguez F, Saeij JPJ.
europepmc   +1 more source

MEPicides: α,β-unsaturated Fosmidomycin N-Acyl Analogs as Efficient Inhibitors of Plasmodium falciparum 1-Deoxy-d-xylulose-5-phosphate reductoisomerase. [PDF]

ACS Infect Dis, 2023
Wang X, Edwards RL, Ball HS, Heidel KM, Brothers RC, Johnson C, Haymond A, Girma M, Dailey A, Roma JS, Boshoff HI, Osbourn DM, Meyers MJ, Couch RD, Odom John AR, Dowd CS.   +15 more
europepmc   +1 more source

The Fsr transporter of <i>Sinorhizobium meliloti</i> contributes to antimicrobial resistance and symbiosis with alfalfa. [PDF]

Microbiology (Reading)
Chávez-Jacobo VM, Reyes-González AR, Girard L, Dunn MF.   +3 more
europepmc   +1 more source

Expression of toxic genes in Methylorubrum extorquens with a tightly repressed, cumate-inducible promoter. [PDF]

Antonie Van Leeuwenhoek, 2023
Pöschel L, Gehr E, Jordan P, Sonntag F, Buchhaupt M.   +4 more
europepmc   +1 more source